Intraviteal injection of povidone iodine resulting in 0.025% vitreal concentration for initial treatment of endophthalmitis

Intraviteal injection of povidone iodine resulting in 0.025% vitreal concentration for initial treatment of endophthalmitis - Initial treatment of endophthalmitis using 0.025% vitreal concentration PI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021114

Enrollment

Registered

2016-02-20

Start date

2015-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endophthalmitis

Interventions

povidone iodine(1.25mg/0.1ml)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cases of endophthalmitis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
postoperative complications due to intravitreal povidone iodine after 3-months	—

Secondary

Measure	Time frame
The result of bacterial culture before intravitreal injection and after vitrectomy, 3-months postoperative visual acuity, recurrence of endophthalmitis within 3 months, operative complicatios	—

Countries

Japan

Contacts

Public ContactHiroyuki Nakashizuka

Nihon University hospital Ophthalmology

nakashizuka.hiroyuki@nihon-u.ac.jp03-3293-1711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026